Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

A-1264087, a novel calcium channel blocker with antinociceptive activity

Oct. 18, 2012

Actelion presented results of cadazolid preclinical and phase I studies

Oct. 18, 2012

Serum amyloid A shows potential as a novel biomarker

Oct. 18, 2012

Merck & Co.'s M-676 enhances activity of beta-lactam antibiotics

Oct. 18, 2012

Researchers identify novel peptide biomarker to predict breast cancer bone metastasis

Oct. 17, 2012

Copernicus designs noninvasive method for gene therapy delivery into the brain

Oct. 17, 2012

Novel gene therapy for Huntington's disease presented by Genzyme

Oct. 17, 2012

Novel compound demonstrates potential for stabilizing alpha-synuclein

Oct. 17, 2012

Endoribonuclease Dicer may be a marker for multiple sclerosis

Oct. 16, 2012

Teijin Pharma presents novel CaSR antagonists with promising in vivo activity

Oct. 16, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...